Wegovy Weight-Loss Pill Now Accessible in the UK: Key Information
Wegovy weight loss pill now available – Residents of the UK can now purchase Wegovy, a weight-loss medication, through private pharmacies both on High Street and online. However, the treatment remains unavailable on the National Health Service (NHS) for now. The pill, taken once daily, contains semaglutide, the same active ingredient found in Wegovy injections. Despite this, healthcare professionals recommend combining the medication with a balanced diet and regular exercise for optimal results.
Differences Between Pill and Injection
While both formulations of semaglutide are effective, they differ in administration. The pill offers a non-invasive alternative for those who dislike needles, but its daily regimen may not suit everyone. In contrast, the weekly injection provides flexibility in timing, though it requires refrigeration. Patients must consider their lifestyle and preferences when choosing between the two options.
“The semaglutide in the jab and pill mimics the actions of a hormone called GLP-1, which is released from the intestine after people eat.”
Wegovy works by mimicking GLP-1, a hormone that regulates appetite. This mechanism helps users feel fuller, reduces hunger, and minimizes food cravings. However, side effects like nausea, vomiting, and constipation are common with both forms, though the injection may also cause localized skin reactions such as redness or swelling.
Eligibility Criteria
To qualify for Wegovy, individuals must have a BMI of 30 or higher, typically classified as obese, or a BMI between 27-30 if they have conditions like type 2 diabetes or hypertension. These requirements mirror those for the injectable version, ensuring consistency in who can access the treatment.
Usage and Dosing Guidelines
For best absorption, the pill should be taken on an empty stomach, at least eight hours after the last meal, and 30 minutes before consuming food or beverages. It is advised to take it at the same time daily to establish a routine. The starting dose is 1.5mg per day for the first month, with gradual increases under medical supervision. A full course of treatment may take several months, and weight regain is possible after discontinuation.
“If you miss a dose, skip that day’s dose and get back on track by taking the scheduled dose the next day, advice says.”
Patients currently using the injectable form can transition to the pill with medical guidance, though dosage adjustments may vary based on individual needs. Availability depends on the pharmacy, with some offering limited-time discounts on initial doses. Prices range from £99 for a 1.5mg monthly supply to £199 for the 25mg version, similar to the US launch pricing of $149 (£110) for the 1.5mg dose.
While the pill may eventually offer cost savings compared to injections, its long-term affordability is still under evaluation. Those considering Wegovy should consult a healthcare provider to determine the most suitable option for their health profile and lifestyle. Always review the patient information leaflet and discuss any pre-existing conditions or medications with a doctor before starting treatment.
